- Home
- CXDO vs DERM Comparison
CXDO vs DERM Comparison
Compare CXDO & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXDO | DERM |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.1M | 267.4M |
| IPO Year | 1999 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CXDO | DERM |
|---|---|---|
| Price | $6.19 | $4.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $9.25 | ★ $12.67 |
| AVG Volume (30 Days) | 186.1K | ★ 271.8K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 166.67 | 34.72 |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $68,167,000.00 | $61,858,000.00 |
| Revenue This Year | $38.52 | $66.12 |
| Revenue Next Year | $19.22 | $52.94 |
| P/E Ratio | $38.88 | ★ N/A |
| Revenue Growth | ★ 12.05 | 10.20 |
| 52 Week Low | $3.75 | $4.31 |
| 52 Week High | $7.80 | $9.56 |
Technical Indicators
Market Signals| Indicator | CXDO | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 45.91 | 28.45 |
| Support Level | $6.08 | N/A |
| Resistance Level | $6.73 | $8.05 |
| Average True Range (ATR) | 0.27 | 0.50 |
| MACD | -0.03 | -0.22 |
| Stochastic Oscillator | 31.38 | 17.39 |
Price Performance
Historical ComparisonAbout CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.